To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene MLLT6TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
258 representative clones for gene MLLT6 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
NM_005937.3   .a 1 to 7499 2 to 7500 V33A RefSeq,   7500/7500
(100 %)
1 diff
(100.0 %id)
DB078413 testis .a 1 to 563 2 to 564   tiling clone, capped   563/563
(100 %)
2 diff
(99.7 %id)
U07932   .a 13 to 3294 1 to 3282 V33A Q126T tiling clone,   3282/3282
(100 %)
5 diff
(99.9 %id)
AB209633 Spleen .a 25 to 5495 1 to 5471   tiling clone,   5471/5471
(100 %)
2 diff
(100.0 %id)
DN831285 pooled .a 179 to 749 1 to 571       571/571
(100 %)
0 diff
(100 %id)
DA944164 Spleen .a 302 to 859 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DN831286 pooled .a 379 to 796 418 to 1     Submitted on the opposite strand 418/418
(100 %)
0 diff
(100 %id)
BQ212436 melanotic melanoma, skin .a 662 to 1506 1 to 850       850/852
(99 %)
8 diff
(99.1 %id)
DA809486 brain .a 802 to 1406 2 to 606   capped   605/605
(100 %)
0 diff
(100 %id)
TI_45379086   .a 1301 to 2211 67 to 978       912/979
(93 %)
21 diff
(97.9 %id)
BI488564 brain .a 1308 to 2211 1 to 905       905/906
(99 %)
15 diff
(98.4 %id)
DA856685 placenta .a 1538 to 2087 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DA105215 cerebellum .a 1605 to 2161 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DA187218 amygdala .a 1606 to 2135 2 to 531   capped   530/530
(100 %)
0 diff
(100 %id)
DB097140 testis .a 1607 to 2192 2 to 587   capped   586/586
(100 %)
0 diff
(100 %id)
DA991828 synovial membrane tissue from rheumatioidarthritis .a 1661 to 2195 2 to 536   capped   535/535
(100 %)
0 diff
(100 %id)
DB134197 thymus .a 1682 to 2231 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
BQ214429 embryonal carcinoma, cell line, testis .a 1834 to 2739 1 to 922       922/923
(99 %)
17 diff
(98.2 %id)
DA776826 brain .a 1846 to 2423 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
DA216926 brain .a 1850 to 2380 2 to 532   capped   531/531
(100 %)
0 diff
(100 %id)
AA360288 lymph node .a 1880 to 2149 1 to 270       270/270
(100 %)
0 diff
(100 %id)
TI_154168126   .a 1897 to 2597 92 to 803       712/867
(82 %)
24 diff
(97.3 %id)
TI_1948080564   .a 1905 to 2629 137 to 859   fully sequenced,   723/859
(84 %)
6 diff
(99.4 %id)
TI_1948080739   .a 1905 to 2704 137 to 935   fully sequenced,   799/935
(85 %)
10 diff
(99.0 %id)
CR979123 T-Lymphocytes .a 1989 to 2666 1 to 678       678/678
(100 %)
0 diff
(100 %id)
DB156062 thymus .a 2240 to 2718 2 to 480   capped   479/479
(100 %)
0 diff
(100 %id)
TI_1948080565   .a 2599 to 3293 826 to 130   fully sequenced,   697/826
(84 %)
1 diff
(99.9 %id)
DA441672 tongue, tumor tissue .a 2645 to 3210 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
TI_1948080740   .a 2674 to 3293 751 to 128   fully sequenced,   624/751
(83 %)
1 diff
(99.9 %id)
DB163605 thymus .a 2694 to 3275 2 to 583   capped   582/582
(100 %)
0 diff
(100 %id)
CD580099 brain .a 2830 to 3515 1 to 686       686/686
(100 %)
2 diff
(99.8 %id)
DB221150 trachea .a 2923 to 3477 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DA344552 substantia nigra .a 2990 to 3558 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA836443 placenta .a 2999 to 3477 2 to 480   capped   479/479
(100 %)
0 diff
(100 %id)
CR979247 T-Lymphocytes .a 3081 to 3816 1 to 736       736/738
(99 %)
1 diff
(99.9 %id)
BQ881558 lymph, lymphoma, cell line .a 3282 to 4088 1 to 813       813/929
(87 %)
18 diff
(98.1 %id)
BQ648165 hepatocellular carcinoma, cell line, Liver .a 3507 to 4288 1 to 789       789/974
(81 %)
29 diff
(97.1 %id)
BQ896591 sympathetic trunk .a 3603 to 4353 1 to 755       755/970
(77 %)
18 diff
(98.2 %id)
BQ222793 epithelioid carcinoma, Pancreas .a 3669 to 4571 1 to 914       914/916
(99 %)
32 diff
(96.6 %id)
CR986538 T-Lymphocytes .a 3678 to 4415 1 to 738       738/746
(98 %)
1 diff
(99.9 %id)
BU521631 leiomyosarcoma, uterus .a 3813 to 4646 1 to 851       851/914
(93 %)
28 diff
(97.0 %id)
CT002562 T-Lymphocytes .a 3938 to 4784 1 to 851       851/851
(100 %)
8 diff
(99.1 %id)
BU429921 lymph .a 3977 to 4490 7 to 520       514/520
(98 %)
0 diff
(100 %id)
BU429922 lymph .a 3977 to 4438 7 to 468       462/468
(98 %)
0 diff
(100 %id)
BM543021 embryonal carcinoma, cell line, testis .a 4001 to 4794 1 to 798       798/1062
(75 %)
18 diff
(98.4 %id)
BQ276357 carcinoma, cell line, Prostate .a 4021 to 4915 1 to 900       900/1007
(89 %)
20 diff
(98.1 %id)
DB156008 thymus .a 4037 to 4633 2 to 598   capped   597/597
(100 %)
0 diff
(100 %id)
TI_149314025   .a 4102 to 4883 863 to 91   AAA Possibly primed on the genome, locally A rich (21/26 A in genome downstream of last aligned base) 773/967
(79 %)
14 diff
(98.6 %id)
BM703489 eye, human retina .a 4102 to 4575 1 to 474       474/474
(100 %)
0 diff
(100 %id)
CA314002 Human Lung Epithelial cells, lung .a 4131 to 4881 766 to 19   AAA Possibly primed on the genome, locally A rich (21/26 A in genome downstream of last aligned base) 748/749
(99 %)
3 diff
(99.6 %id)
BG006431 placenta_normal .a 4235 to 4525 306 to 16       291/322
(90 %)
0 diff
(100 %id)
AF075118   .a 4259 to 4880 1 to 620       620/620
(100 %)
1 diff
(99.9 %id)
CK824032 insulinoma, Pancreas .a 4264 to 4775 512 to 1       512/512
(100 %)
0 diff
(100 %id)
BQ448560 Knee, Osteoarthritic Cartilage .a 4303 to 4883 597 to 17   AAA Possibly primed on the genome, locally A rich (21/26 A in genome downstream of last aligned base) 581/581
(100 %)
0 diff
(100 %id)
DB160750 thymus .a 4311 to 4824 2 to 515   capped   514/514
(100 %)
0 diff
(100 %id)
CB305828 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 4383 to 4883 519 to 19   AAA Possibly primed on the genome, locally A rich (21/26 A in genome downstream of last aligned base) 501/501
(100 %)
0 diff
(100 %id)
AW836868 leiomios .a 4514 to 4830 323 to 10       314/326
(96 %)
0 diff
(100 %id)
AW836944 leiomios .a 4514 to 4817 305 to 2       304/308
(98 %)
0 diff
(100 %id)
AW836946 leiomios .a 4514 to 4819 315 to 12       304/318
(95 %)
0 diff
(100 %id)
AW836954 leiomios .a 4514 to 4828 321 to 9       313/324
(96 %)
0 diff
(100 %id)
AW877203 pnet .a 4514 to 4831 330 to 12       319/333
(95 %)
0 diff
(100 %id)
AA259021 germinal center B cell .a 4570 to 5011 1 to 439       439/439
(100 %)
3 diff
(99.4 %id)
BQ439182 epithelioid carcinoma, Pancreas .a 4584 to 5454 1 to 878       878/879
(99 %)
26 diff
(97.1 %id)
DA585237 lung .a 4640 to 5194 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
BQ022572 placenta .a 4692 to 4881 207 to 18   AAA Possibly primed on the genome, locally A rich (21/26 A in genome downstream of last aligned base) 190/190
(100 %)
0 diff
(100 %id)
AU185631 skin .a 4840 to 5195 1 to 356       356/356
(100 %)
0 diff
(100 %id)
DA300396 hippocampus .a 4906 to 5478 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
BU952136 Pancreas, Purified pancreatic islet .a 4907 to 5221 1 to 315   fully sequenced,   315/315
(100 %)
0 diff
(100 %id)
TI_154167425   .a 5027 to 5505 557 to 80     Submitted on the opposite strand 478/479
(99 %)
0 diff
(100 %id)
AA090380   .a 5038 to 5320 275 to 2     Submitted on the opposite strand 274/286
(95 %)
0 diff
(100 %id)
BE796499 lung, small cell carcinoma .a 5051 to 5862 1 to 813       813/965
(84 %)
21 diff
(97.9 %id)
TI_59391961   .a 5064 to 5897 125 to 953       829/830
(99 %)
14 diff
(98.4 %id)
BM014011 breast, mammary adenocarcinoma, cell line .a 5066 to 5897 1 to 827       827/828
(99 %)
14 diff
(98.4 %id)
AI613465 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 5071 to 5497 427 to 1       427/427
(100 %)
0 diff
(100 %id)
AK092893 Spleen .a 5073 to 7495 1 to 2422   tiling clone, available from FLJ,   2422/2422
(100 %)
2 diff
(100.0 %id)
DA935028 Spleen .a 5074 to 5655 2 to 582   capped   581/581
(100 %)
2 diff
(99.7 %id)
AA258216 germinal center B cell .a 5078 to 5497 420 to 1       420/420
(100 %)
5 diff
(98.9 %id)
AA569591   .a 5086 to 5503 417 to 1       417/427
(97 %)
6 diff
(98.6 %id)
AA458534 ovarian tumor, ovary .a 5106 to 5491 1 to 386   fully sequenced,   386/386
(100 %)
0 diff
(100 %id)
BF876080 lung_tumor .a 5137 to 5252 116 to 1     Submitted on the opposite strand 116/116
(100 %)
0 diff
(100 %id)
CR990603 T-Lymphocytes .a 5141 to 5852 1 to 718       718/720
(99 %)
8 diff
(98.9 %id)
BU951876 Pancreas, Purified pancreatic islet .a 5191 to 5496 306 to 1   fully sequenced,   306/306
(100 %)
1 diff
(99.7 %id)
BF876068 lung_tumor .a 5269 to 5561 306 to 14     Submitted on the opposite strand 293/306
(95 %)
0 diff
(100 %id)
BI062210 uterus_tumor .a 5269 to 5731 463 to 1       463/463
(100 %)
7 diff
(98.5 %id)
BI905813 leukocyte .a 5325 to 6086 1 to 771       771/978
(78 %)
15 diff
(98.5 %id)
AA454610 ovarian tumor, ovary .a 5347 to 5498 151 to 1   fully sequenced,   151/151
(100 %)
0 diff
(100 %id)
CF619406 Pooled Chondrosarcoma Tumor cells .a 5353 to 6096 33 to 783       751/933
(80 %)
16 diff
(98.3 %id)
BQ925230 sciatic nerve .a 5359 to 6196 1 to 852       852/914
(93 %)
39 diff
(95.8 %id)
BQ233076 large cell carcinoma, lung .a 5448 to 6390 1 to 956   tiling clone,   956/1113
(85 %)
31 diff
(97.3 %id)
TI_149307887   .a 5477 to 6028 86 to 637     Submitted on the opposite strand 552/1006
(54 %)
4 diff
(99.7 %id)
DA045456 bladder .a 5506 to 6043 2 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
DA943832 Spleen .a 5519 to 6088 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
AA349356 brain .a 5528 to 5936 1 to 409       409/409
(100 %)
0 diff
(100 %id)
CX166375 human embryonic stem cells differentiated toan early endodermal cell type .a 5528 to 6288 1 to 761       761/761
(100 %)
0 diff
(100 %id)
AY459295   .a 5529 to 5894 366 to 1     Submitted on the opposite strand 366/366
(100 %)
0 diff
(100 %id)
BG325190 Kidney, renal cell adenocarcinoma .a 5562 to 6311 1 to 756       756/972
(77 %)
29 diff
(97.1 %id)
BG324993 Kidney, renal cell adenocarcinoma .a 5562 to 6157 1 to 588       588/913
(64 %)
10 diff
(99.0 %id)
DA843805 placenta .a 5597 to 6174 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
DA931014 small intestine .a 5603 to 6182 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
BF346897 anaplastic oligodendroglioma with 1p/19qloss, brain .a 5612 to 6405 1 to 787       787/793
(99 %)
24 diff
(97.0 %id)
BE798152 lung, small cell carcinoma .a 5647 to 6429 28 to 801       774/1024
(75 %)
22 diff
(97.9 %id)
BE561615 Burkitt lymphoma, lymph .a 5662 to 6430 36 to 793       758/931
(81 %)
21 diff
(97.8 %id)
AK057058   .a 5671 to 7495 1 to 1828   available from FLJ,   1828/1828
(100 %)
4 diff
(99.8 %id)
DA908187   .a 5672 to 6165 2 to 495   capped Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 494/494
(100 %)
0 diff
(100 %id)
BF346628 anaplastic oligodendroglioma with 1p/19qloss, brain .a 5689 to 6506 1 to 819       819/1044
(78 %)
28 diff
(97.4 %id)
DA929938 small intestine .a 5724 to 6294 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
Z42297 brain, total brain .a 5771 to 5970 1 to 201       201/201
(100 %)
1 diff
(99.6 %id)
CT004265 T-Lymphocytes .a 5806 to 6220 1 to 415       415/415
(100 %)
0 diff
(100 %id)
DA568242 whole embryo, mainly head .a 5819 to 6323 2 to 505   capped   504/504
(100 %)
2 diff
(99.7 %id)
BU162205 eye, retinoblastoma .a 5842 to 6697 1 to 870       870/873
(99 %)
21 diff
(97.6 %id)
CB215830 normal endometrium, late proliferativephase, cycle day 13, uterus .a 6005 to 6610 1 to 606       606/606
(100 %)
0 diff
(100 %id)
BM686633 eye, optic nerve .a 6041 to 6661 1 to 620     Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 620/620
(100 %)
5 diff
(99.2 %id)
BQ212642 embryonal carcinoma, cell line, testis .a 6087 to 6858 1 to 777       777/958
(81 %)
12 diff
(98.8 %id)
BY799224 eye .a 6091 to 6721 1 to 631       631/631
(100 %)
0 diff
(100 %id)
BG260804 bladder, transitional cell papilloma, cell line .a 6094 to 6857 1 to 755       755/885
(85 %)
19 diff
(97.9 %id)
BU517014 leiomyosarcoma, uterus .a 6144 to 7021 5 to 889       885/889
(99 %)
6 diff
(99.4 %id)
BQ901187 epidermoid carcinoma, cell line, lung .a 6262 to 6967 1 to 711       711/863
(82 %)
6 diff
(99.4 %id)
BG676191 skin, squamous cell carcinoma .a 6335 to 7197 1 to 868       868/868
(100 %)
12 diff
(98.7 %id)
TI_57148027   .a 6363 to 7219 32 to 886       855/890
(96 %)
16 diff
(98.3 %id)
BQ950783 large cell carcinoma, lung .a 6367 to 7271 20 to 930       911/934
(97 %)
18 diff
(98.1 %id)
BI760193 pooled colon, kidney, stomach .a 6368 to 7219 1 to 850       850/854
(99 %)
13 diff
(98.5 %id)
DB331365   .a 6932 to 7474 567 to 25   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 543/543
(100 %)
0 diff
(100 %id)
DB332769 Spleen .a 6933 to 7495 564 to 1       564/564
(100 %)
1 diff
(99.9 %id)
DB354731 whole embryo, mainly head .a 6951 to 7474 521 to 1       521/522
(99 %)
8 diff
(98.5 %id)
BU728002 eye, optic nerve .a 6997 to 7474 496 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 478/478
(100 %)
1 diff
(99.8 %id)
Z38531 brain, total brain .a 7243 to 7474 232 to 1       232/232
(100 %)
0 diff
(100 %id)
AL133659 testis .b 1 to 3863 1 to 3863 exact tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (21/26 A in genome downstream of last aligned base) 3863/3863
(100 %)
1 diff
(100.0 %id)
AK310435 testis .c 1 to 1363 2 to 1364 V37A N174S tiling clone,   1364/1364
(100 %)
2 diff
(99.9 %id)
AK310437 testis .c 1 to 1555 2 to 1556 V37A N174S     1556/1556
(100 %)
2 diff
(99.9 %id)
BQ328177 kidney_tumor .c 771 to 1291 561 to 44       518/561
(92 %)
0 diff
(100 %id)
BF746230 breast .c 901 to 1202 310 to 9     Submitted on the opposite strand 302/310
(97 %)
0 diff
(100 %id)
BF746300 breast .c 901 to 1202 310 to 9     Submitted on the opposite strand 302/310
(97 %)
0 diff
(100 %id)
BF744123 breast .c 1116 to 1210 8 to 100       93/100
(93 %)
6 diff
(94.0 %id)
BI046889 prostate_normal .c 1301 to 1692 411 to 20   tiling clone,   392/411
(95 %)
0 diff
(100 %id)
CA391519 eye, RPE/choroid .c 1470 to 2070 1 to 601   tiling clone,   601/601
(100 %)
0 diff
(100 %id)
DB280441 uterus .c 1558 to 2101 2 to 545   capped   544/544
(100 %)
1 diff
(99.9 %id)
BE304738 adenocarcinoma cell line, colon .c 1932 to 2611 1 to 683   tiling clone,   683/755
(90 %)
26 diff
(96.6 %id)
BE293238 adenocarcinoma cell line, colon .c 1932 to 2604 1 to 669   tiling clone,   669/676
(98 %)
11 diff
(98.4 %id)
BC064612 Eye, retinoblastoma .d 1 to 2706 6 to 2711 V33A tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (21/26 A in genome downstream of last aligned base) 2706/2711
(99 %)
7 diff
(99.8 %id)
TI_1948215782   .d 89 to 616 126 to 653   fully sequenced,   528/653
(80 %)
7 diff
(99.0 %id)
TI_1948215453   .d 97 to 616 131 to 650   fully sequenced,   520/650
(80 %)
7 diff
(99.0 %id)
TI_1948215616   .d 97 to 1078 131 to 1100 V33A E235R R236G G237A Q238R ... fully sequenced,   970/1100
(88 %)
57 diff
(94.9 %id)
TI_1948215935   .d 97 to 616 129 to 648   fully sequenced,   520/648
(80 %)
7 diff
(99.0 %id)
TI_1948215454   .d 586 to 1073 614 to 127   fully sequenced,   488/614
(79 %)
0 diff
(100 %id)
TI_1948215783   .d 586 to 1073 613 to 124   fully sequenced,   490/613
(79 %)
3 diff
(99.6 %id)
TI_1948215936   .d 586 to 1073 613 to 124   fully sequenced,   490/613
(79 %)
3 diff
(99.6 %id)
TI_1948215617   .d 618 to 1073 580 to 125   fully sequenced,   456/580
(78 %)
0 diff
(100 %id)
AI744791 ovary, tumor, 5 pooled (see description) .d 1824 to 2202 389 to 11   AAA   379/379
(100 %)
9 diff
(97.7 %id)
AL046526 testis .d 2438 to 2933 496 to 1   tiling clone, Submitted on the opposite strand 496/496
(100 %)
2 diff
(99.6 %id)
DB381155 placenta .d 2729 to 3281 549 to 1   tiling clone,   549/549
(100 %)
13 diff
(97.7 %id)
CV425188 placenta_normal .d 3040 to 3405 368 to 3   tiling clone, Submitted on the opposite strand 366/368
(99 %)
0 diff
(100 %id)
CV425197 placenta_normal .d 3040 to 3405 368 to 3     Submitted on the opposite strand 366/368
(99 %)
0 diff
(100 %id)
BC007859 Uterus, leiomyosarcoma .e 1 to 1208 1 to 1208 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (21/26 A in genome downstream of last aligned base) 1208/1208
(100 %)
0 diff
(100 %id)
BF683363 leiomyosarcoma cell line, uterus .e 1 to 665 1 to 656   available from MGC,   656/774
(84 %)
14 diff
(98.2 %id)
AW848203 colon .e 832 to 1366 1 to 535       535/535
(100 %)
4 diff
(99.3 %id)
AW848633 colon .e 832 to 1293 1 to 462       462/462
(100 %)
0 diff
(100 %id)
AW848693 colon .e 832 to 1209 1 to 378       378/378
(100 %)
4 diff
(99.0 %id)
AW848695 colon .e 832 to 1295 1 to 464       464/464
(100 %)
0 diff
(100 %id)
BE350771 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .e 843 to 1128 286 to 1       286/286
(100 %)
0 diff
(100 %id)
AW848125 colon .e 867 to 1384 518 to 1   tiling clone,   518/518
(100 %)
2 diff
(99.7 %id)
AW848124 colon .e 929 to 1384 456 to 1       456/456
(100 %)
0 diff
(100 %id)
BX648298 human uterus .f-u 1 to 2932 1 to 2935 S126T S146C V147L C148S L149A ... tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (21/26 A in genome downstream of last aligned base) 2935/2935
(100 %)
4 diff
(99.9 %id)
DA953654 Spleen .f-u 1254 to 1822 2 to 572   capped   571/571
(100 %)
2 diff
(99.7 %id)
CF137370 lymph .g 1 to 450 8 to 457       450/457
(98 %)
0 diff
(100 %id)
TI_154166807   .g 1 to 470 81 to 550 exact tiling clone,   470/470
(100 %)
0 diff
(100 %id)
AA147396 Pancreas .h 1 to 398 1 to 400   tiling clone,   400/400
(100 %)
10 diff
(97.5 %id)
CA848153 Pancreas, Purified pancreatic islet .h 251 to 736 486 to 1   tiling clone,   486/486
(100 %)
0 diff
(100 %id)
AA147397 Pancreas .h 491 to 738 247 to 1   tiling clone,   247/251
(98 %)
4 diff
(98.5 %id)
BF928271 nervous_tumor .i 1 to 292 293 to 1 V36A G85E E86* tiling clone, Submitted on the opposite strand 293/293
(100 %)
2 diff
(99.4 %id)
AL832481 cervix .j 1 to 2485 1 to 2485 exact tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 2485/2485
(100 %)
0 diff
(100 %id)
BE387140 melanotic melanoma, skin .j 770 to 1259 1 to 490 exact     490/499
(98 %)
5 diff
(99.0 %id)
BF338168 brain, glioblastoma with EGFR amplification .j 1373 to 2194 1 to 811       811/824
(98 %)
26 diff
(96.9 %id)
DB149083 thymus .j 1423 to 1894 2 to 473   capped   472/472
(100 %)
0 diff
(100 %id)
BQ669675 epidermoid carcinoma, cell line, salivary gland .j 1428 to 2241 1 to 822       822/935
(87 %)
21 diff
(97.8 %id)
BQ710187 Spleen .j 1435 to 2246 1 to 819       819/928
(88 %)
22 diff
(97.7 %id)
BG468286 adenocarcinoma cell line, colon .j 1441 to 2208 1 to 769       769/772
(99 %)
19 diff
(97.6 %id)
BQ917315 epidermoid carcinoma, cell line, lung .j 1516 to 2441 1 to 922       922/925
(99 %)
10 diff
(99.0 %id)
TI_227714284   .j 1516 to 2485 1032 to 91   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 942/971
(97 %)
30 diff
(97.0 %id)
DA899842 skeletal muscle .j 1539 to 2030 2 to 493   fully sequenced, capped   492/492
(100 %)
0 diff
(100 %id)
BM050048 epithelioid carcinoma cell line, Pancreas .j 1543 to 2387 1 to 845       845/945
(89 %)
32 diff
(96.7 %id)
BU194863 melanotic melanoma, skin .j 1547 to 2192 1 to 645       645/852
(75 %)
5 diff
(99.5 %id)
BM561957 blood, natural killer cells, cell line .j 1568 to 2485 952 to 21   AAA Submitted on the opposite strand 932/959
(97 %)
22 diff
(97.8 %id)
TI_59385745   .j 1571 to 2362 68 to 862       795/797
(99 %)
35 diff
(95.7 %id)
TI_149286489   .j 1612 to 2485 949 to 84   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 866/1164
(74 %)
29 diff
(97.6 %id)
TI_149298679   .j 1612 to 2485 943 to 95   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 849/915
(92 %)
26 diff
(97.2 %id)
TI_149292191   .j 1619 to 2485 924 to 78   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 847/910
(93 %)
25 diff
(97.3 %id)
BF884092 lung_tumor .j 1634 to 2062 1 to 429       429/429
(100 %)
0 diff
(100 %id)
AA378705 synovial membrane .j 1638 to 1815 1 to 178       178/178
(100 %)
0 diff
(100 %id)
AW964167   .j 1639 to 2368 1 to 735       735/735
(100 %)
14 diff
(98.1 %id)
TI_149286490   .j 1663 to 2485 888 to 86   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 803/1124
(71 %)
29 diff
(97.5 %id)
TI_57202096   .j 1675 to 2508 31 to 860       830/1106
(75 %)
23 diff
(98.0 %id)
BI822899 pooled brain, lung, testis .j 1679 to 2508 1 to 826       826/834
(99 %)
21 diff
(97.5 %id)
TI_154131633   .j 1679 to 2485 883 to 88   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 796/973
(81 %)
15 diff
(98.5 %id)
BQ787128 Pancreas, Purified pancreatic islet .j 1702 to 2051 1 to 350   fully sequenced,   350/350
(100 %)
6 diff
(98.3 %id)
TI_154128456   .j 1707 to 2485 861 to 94   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 768/931
(82 %)
17 diff
(98.2 %id)
BU607458 Human Lung Epithelial cells, lung .j 1741 to 2485 762 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 744/744
(100 %)
1 diff
(99.9 %id)
BU624160 cell lines, Enchondroma .j 1752 to 2485 751 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 733/733
(100 %)
1 diff
(99.9 %id)
BQ015544 Chondrosarcoma, Left Pelvis .j 1762 to 2485 742 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 724/724
(100 %)
0 diff
(100 %id)
BM974394 lung .j 1784 to 2485 718 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 700/702
(99 %)
2 diff
(99.8 %id)
BM694672 eye, RPE and Choroid .j 1794 to 2074 1 to 281   fully sequenced,   281/281
(100 %)
0 diff
(100 %id)
AA262859 germinal center B cell .j 1821 to 2164 1 to 343       343/343
(100 %)
1 diff
(99.8 %id)
AA335962 epididymis .j 1823 to 2091 1 to 269       269/269
(100 %)
0 diff
(100 %id)
BQ019717 Chondrosarcoma, Left Pubic Bone .j 1835 to 2485 669 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 651/651
(100 %)
0 diff
(100 %id)
BM989335 Fibrosarcoma .j 1836 to 2485 668 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 650/650
(100 %)
0 diff
(100 %id)
BQ000412 Fibrosarcoma .j 1837 to 2485 667 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 649/649
(100 %)
0 diff
(100 %id)
CA417548 Chondrosarcoma Cell line .j 1837 to 2485 667 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 649/649
(100 %)
0 diff
(100 %id)
CA418123 Bone, Human Chondrosarcoma Cell Line .j 1837 to 2485 667 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 649/649
(100 %)
0 diff
(100 %id)
BU615311 Bone, Human Chondrosarcoma Cell Line .j 1837 to 2485 667 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 649/649
(100 %)
0 diff
(100 %id)
BU634536 cell lines, Chondrosarcoma .j 1837 to 2485 667 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 649/649
(100 %)
0 diff
(100 %id)
CD366508 Alveolar Macrophage, lung .j 1837 to 2485 667 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 649/649
(100 %)
0 diff
(100 %id)
BQ180876 Knee, Osteoarthritic Cartilage .j 1838 to 2485 666 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 648/648
(100 %)
4 diff
(99.4 %id)
BQ183461 Knee, Osteoarthritic Cartilage .j 1839 to 2485 665 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 647/647
(100 %)
0 diff
(100 %id)
CA428627 Cell Line, Chondrosarcoma .j 1901 to 2485 603 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 585/585
(100 %)
0 diff
(100 %id)
CA309205 Alveolar Macrophage, lung .j 1905 to 2501 597 to 1       597/597
(100 %)
0 diff
(100 %id)
BU526755 epidermoid carcinoma, cell line, lung .j 1923 to 2485 1 to 563   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 563/563
(100 %)
0 diff
(100 %id)
BI013276 lung_tumor .j 1934 to 2230 297 to 1       297/298
(99 %)
0 diff
(100 %id)
AI951767 brain, four pooled pituitary adenomas .j 1946 to 2486 541 to 1       541/541
(100 %)
0 diff
(100 %id)
AW007590 colon .j 1978 to 2487 510 to 1       510/510
(100 %)
0 diff
(100 %id)
BX091676 whole brain .j 1986 to 2499 514 to 1       514/514
(100 %)
0 diff
(100 %id)
AW027140 thymus, pooled .j 1988 to 2486 499 to 1       499/499
(100 %)
0 diff
(100 %id)
AA040629 uterus .j 1989 to 2490 8 to 509   fully sequenced,   502/509
(98 %)
3 diff
(99.5 %id)
DB331106 skeletal muscle .j 2000 to 2485 487 to 1   fully sequenced,   487/487
(100 %)
1 diff
(99.8 %id)
AA417180   .j 2008 to 2364 1 to 356   fully sequenced,   356/356
(100 %)
2 diff
(99.5 %id)
AW304320 lung, two pooled squamous cell carcinomas .j 2019 to 2487 469 to 1       469/469
(100 %)
0 diff
(100 %id)
AI935907 adenocarcinoma, Pancreas .j 2020 to 2493 474 to 1       474/474
(100 %)
0 diff
(100 %id)
BQ786856 Pancreas, Purified pancreatic islet .j 2021 to 2486 466 to 1   fully sequenced,   466/466
(100 %)
0 diff
(100 %id)
BM989268 Fibrosarcoma .j 2029 to 2502 474 to 1       474/474
(100 %)
0 diff
(100 %id)
AW517225 cervix .j 2030 to 2492 463 to 1       463/463
(100 %)
0 diff
(100 %id)
AA353049   .j 2031 to 2350 1 to 320       320/320
(100 %)
0 diff
(100 %id)
AI249764 Kidney .j 2036 to 2485 450 to 1       450/450
(100 %)
0 diff
(100 %id)
AI475899 B-cell, chronic lymphotic leukemia .j 2036 to 2492 457 to 1       457/457
(100 %)
0 diff
(100 %id)
AI627758 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .j 2036 to 2485 450 to 1       450/450
(100 %)
0 diff
(100 %id)
AI129502 uterus .j 2041 to 2485 445 to 1       445/445
(100 %)
0 diff
(100 %id)
AI399983 B-cell, chronic lymphotic leukemia .j 2044 to 2486 443 to 1       443/443
(100 %)
0 diff
(100 %id)
AI566500 adenocarcinoma, Pancreas .j 2044 to 2489 446 to 1       446/446
(100 %)
0 diff
(100 %id)
BU731196 eye, RPE and Choroid .j 2044 to 2503 460 to 1   fully sequenced,   460/460
(100 %)
2 diff
(99.6 %id)
AW057832 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .j 2045 to 2488 444 to 1       444/444
(100 %)
0 diff
(100 %id)
AA583001 colon, colon tumor RER+ .j 2047 to 2484 438 to 1       438/438
(100 %)
0 diff
(100 %id)
AI143123 heart .j 2059 to 2488 430 to 1       430/430
(100 %)
0 diff
(100 %id)
AA724635 parathyroid gland, parathyroid tumor .j 2074 to 2493 420 to 1       420/420
(100 %)
0 diff
(100 %id)
AW129991 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .j 2083 to 2509 427 to 1   tiling clone,   427/427
(100 %)
0 diff
(100 %id)
AI368959 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .j 2091 to 2492 402 to 1       402/403
(99 %)
0 diff
(100 %id)
AI092814 heart .j 2097 to 2489 393 to 1       393/393
(100 %)
0 diff
(100 %id)
AA932452 2 pooled tumors (clear cell type), Kidney .j 2102 to 2488 387 to 1       387/387
(100 %)
0 diff
(100 %id)
AI241962 brain, tumor, 5 pooled (see description) .j 2102 to 2488 387 to 1       387/387
(100 %)
0 diff
(100 %id)
AI690783 serous papillary carcinoma, high grade, 2pooled tumors, uterus .j 2111 to 2491 381 to 1       381/381
(100 %)
0 diff
(100 %id)
BG236044 blood, lymphocyte .j 2116 to 2484 369 to 1       369/369
(100 %)
0 diff
(100 %id)
AI284418 Kidney .j 2120 to 2485 366 to 1       366/366
(100 %)
0 diff
(100 %id)
AI701961 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .j 2138 to 2485 368 to 21   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 348/348
(100 %)
0 diff
(100 %id)
AA039982 uterus .j 2186 to 2485 312 to 1   fully sequenced,   312/312
(100 %)
1 diff
(99.7 %id)
T32899 adrenal gland .j 2198 to 2485 288 to 1       288/288
(100 %)
0 diff
(100 %id)
T32898 adrenal gland .j 2205 to 2485 281 to 1       281/281
(100 %)
0 diff
(100 %id)
BI756576 brain .j 2265 to 2857 1 to 606   tiling clone,   606/707
(85 %)
27 diff
(96.2 %id)
TI_57220014   .j 2265 to 2857 33 to 638       606/739
(82 %)
27 diff
(96.4 %id)
BM463396 embryonal carcinoma, cell line, testis .j 2276 to 2485 1 to 210   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 210/210
(100 %)
0 diff
(100 %id)
AA738040 pooled germ cell tumors .j 2283 to 2500 218 to 1       218/218
(100 %)
0 diff
(100 %id)
BE677596 dorsal root ganglia .j 2321 to 2486 166 to 1       166/166
(100 %)
0 diff
(100 %id)
AA417049   .j 2335 to 2493 159 to 1   fully sequenced,   159/159
(100 %)
0 diff
(100 %id)
AA868928   .j 2360 to 2495 136 to 1       136/136
(100 %)
0 diff
(100 %id)
AA262779 germinal center B cell .j 2368 to 2508 141 to 1       141/141
(100 %)
0 diff
(100 %id)
D19911   .j 2399 to 2488 1 to 90     Submitted on the opposite strand 90/90
(100 %)
0 diff
(100 %id)
AA815126 germinal center B cell .j 2408 to 2494 87 to 1       87/87
(100 %)
0 diff
(100 %id)
DB149257 thymus .k 1 to 482 2 to 484   tiling clone, capped   483/483
(100 %)
1 diff
(99.8 %id)
BG980848 colon_normal .k 34 to 354 1 to 322   tiling clone,   322/322
(100 %)
7 diff
(97.9 %id)
BF476002 Prostate .k 309 to 968 660 to 1 Q58T R59L L61S H62S P63G     660/692
(95 %)
12 diff
(98.3 %id)
BF446408 Prostate .k 312 to 968 655 to 1 E2X P10A S11T T12H S13P ... tiling clone,   655/690
(94 %)
13 diff
(98.2 %id)
CN430295 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .k 456 to 1039 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
BQ300925 bladder_tumor .k 701 to 978 281 to 1       281/281
(100 %)
5 diff
(98.3 %id)
DW412724 Liver .k 724 to 960 87 to 323       237/323
(73 %)
6 diff
(98.2 %id)
DA834085 placenta .k 826 to 1544 2 to 720   tiling clone, capped   719/719
(100 %)
3 diff
(99.6 %id)
BE551331 carcinoid, lung .k 836 to 1299 1 to 464     Submitted on the opposite strand 464/464
(100 %)
0 diff
(100 %id)
AA995367 carcinoid, lung .k 842 to 1240 1 to 398     Submitted on the opposite strand 398/398
(100 %)
1 diff
(99.8 %id)
BY796383 eye .l-u 1 to 518 1 to 517 exact tiling clone,   517/517
(100 %)
1 diff
(99.9 %id)
DB138950 thymus .l-u 12 to 455 2 to 446 exact tiling clone, capped   445/454
(98 %)
3 diff
(99.4 %id)
AA812940   .m 1 to 394 406 to 14 R4T G11A L13F P16R H17T ... tiling clone, AAA Possibly primed on the genome, locally A rich (21/26 A in genome downstream of last aligned base) 393/393
(100 %)
4 diff
(99.0 %id)
R36221 placenta .n-u 1 to 297 15 to 316 D13A G14V S15A S16P P17Q ... tiling clone, AAA   302/354
(85 %)
11 diff
(96.9 %id)
AW820918 stomach Gene MLLT6, variant not shown              
DB327342 brain Gene MLLT6, variant not shown              
DA809887 brain Gene MLLT6, variant not shown       capped      
BU686799 lung, Primary Lung Epithelial Cells Gene MLLT6, variant not shown         Submitted on the opposite strand    
420 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f-u, .g, .h, .i, .j, .k, .l-u, .m, .n-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI